Hyperparathyroidism Clinical Trials

Birmingham : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Birmingham : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Tucson :

A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism

Little Rock : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Los Angeles : Site Reference ID/Investigator# 55342

A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis

Los Angeles : Site Reference ID/Investigator# 48565

A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis

Los Angeles : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Los Angeles : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Los Angeles : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

View More »

San Francisco : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Gainesville : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Atlanta : Site Reference ID/Investigator# 53324

A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis

Bannockburn : Cytochroma Inc.

Safety and Efficacy of CTAP101 Capsules to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency

Iowa City : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Louisville : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Baltimore : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Baltimore : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Boston : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Royal Oak : William Beaumont Health Center

Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery

Kansas City : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Kansas City : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Kansas City : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

St Louis : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

St. Louis :

A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism

View More »

St. Louis : Site Reference ID/Investigator# 48555

A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis

St. Louis : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Livingston : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Bronx : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

New York : Columbia University Medical Center

Denosumab in Primary Hyperparathyroidism

Greenville : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Greenville : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Cincinnati : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Cincinnati : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Oklahoma City : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Portland : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Philadelphia : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Philadelphia : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Dallas : Site Reference ID/Investigator# 53326

A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis

Greenville :

A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism

Houston : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Houston : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

San Antonio : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

View More »

San Antonio : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Salt Lake City : Site Reference ID/Investigator# 48566

A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis

Charlottesville : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Madison :

A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism

Herston : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Parkville : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Randwick : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Westmead : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Feldkirch : Site Reference ID/Investigator# 64522

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Graz : Site Reference ID/Investigator# 53506

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Innsbruck : Site Reference ID/Investigator# 74733

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Rottenmann : Site Reference ID/Investigator# 64523

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

St. Poelten : Site Reference ID/Investigator# 53526

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

View More »

Steyr : Site Reference ID/Investigator# 69662

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Vienna : Site Reference ID/Investigator# 53523

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Vienna : Site Reference ID/Investigator# 53507

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Vienna : Site Reference ID/Investigator# 53508

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Bruxelles : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Edegem : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Gent : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Gent : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

Leuven : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

View More »

Leuven : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

Praha 5 : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Aachen : Site Reference ID/Investigator# 28352

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Alsfeld : Site Reference ID/Investigator# 28359

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Arnstadt : Site Reference ID/Investigator# 28305

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Aschersleben : Site Reference ID/Investigator# 28306

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Augsburg : Site Reference ID/Investigator# 28003

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

View More »

Aurich : Site Reference ID/Investigator# 81613

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Bad Bevensen : Site Reference ID/Investigator# 28017

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Bad Nenndorf : Site Reference ID/Investigator# 28301

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Balingen : Site Reference ID/Investigator# 28296

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Berlin : Site Reference ID/Investigator# 54050

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Berlin : Site Reference ID/Investigator# 28303

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Berlin : Site Reference ID/Investigator# 28021

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Bernburg : Site Reference ID/Investigator# 28022

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Betzdorf : Site Reference ID/Investigator# 30862

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Bielefeld : Site Reference ID/Investigator# 28007

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Burg : Site Reference ID/Investigator# 28304

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Coburg : Site Reference ID/Investigator# 28014

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Cottbus : Site Reference ID/Investigator# 28023

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Demmin : Site Reference ID/Investigator# 28134

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Dresden : Site Reference ID/Investigator# 43903

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Elsenfeld : Site Reference ID/Investigator# 28284

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Erfurt : Site Reference ID/Investigator# 48864

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Erkelenz : Site Reference ID/Investigator# 72343

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Eschweiler : Site Reference ID/Investigator# 28029

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Friedrichroda : Site Reference ID/Investigator# 28287

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Gera : Site Reference ID/Investigator# 28276

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Halle : Site Reference ID/Investigator# 28351

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Hamburg : Site Reference ID/Investigator# 28280

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Hannover : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

Hanover : Site Reference ID/Investigator# 48865

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Heidelberg : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Heidelberg : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Heidelberg : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

Heilbronn : Site Reference ID/Investigator# 28300

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Herford : Site Reference ID/Investigator# 28011

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Herzberg : Site Reference ID/Investigator# 28019

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Hildesheim : Site Reference ID/Investigator# 28135

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Hoyerswerda : Site Reference ID/Investigator# 28286

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Ilfeld : Site Reference ID/Investigator# 28353

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Jena : Site Reference ID/Investigator# 28044

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Kiel : Site Reference ID/Investigator# 48863

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Lahr : Site Reference ID/Investigator# 28013

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Loerrach : Site Reference ID/Investigator# 28025

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Ludwigslust : Site Reference ID/Investigator# 28290

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Magdeburg : Site Reference ID/Investigator# 10982

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Malente : Site Reference ID/Investigator# 28291

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Mannheim : Site Reference ID/Investigator# 28036

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Marburg : Site Reference ID/Investigator# 28302

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Marburg : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Muellheim : Site Reference ID/Investigator# 28278

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Nordhorn : Site Reference ID/Investigator# 28275

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Oberstdorf : Site Reference ID/Investigator# 43904

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Osnabrueck : Site Reference ID/Investigator# 28277

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Peine : Site Reference ID/Investigator# 28297

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Pirmasens : Site Reference ID/Investigator# 28307

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Potsdam : Site Reference ID/Investigator# 28295

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Quedlinburg : Site Reference ID/Investigator# 28294

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Rendsburg : Site Reference ID/Investigator# 48862

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Ribnitz-Damgarten : Site Reference ID/Investigator# 28042

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Rostock : Site Reference ID/Investigator# 28282

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

St. Wendel : Site Reference ID/Investigator# 28033

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Stuttgart : Site Reference ID/Investigator# 28005

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Stuttgart : Site Reference ID/Investigator# 54052

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Viersen : Site Reference ID/Investigator# 28020

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Villingen-Schwenningen : Site Reference ID/Investigator# 28293

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Voelklingen : Site Reference ID/Investigator# 28018

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Weissenfels : Site Reference ID/Investigator# 28298

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Wetzlar : Site Reference ID/Investigator# 28292

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Wiesbaden : Site Reference ID/Investigator# 48882

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Wolfenbuettel : Site Reference ID/Investigator# 28299

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Zwickau : Site Reference ID/Investigator# 28279

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Budapest : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Budapest : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Debrecen : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Debrecen : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Pecs : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

View More »

Szeged : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Szeged : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Jerusalem. : Endocrinology Clinic, Clalit Health Services

Vitamin D Status in Males in Jerusalem Area and Its Correlation to Parathyroid Hormone (PTH) Level and Bone Mineral Density

Acquaviva delle Fonti : Ospedale generale regionale "Miulli"

Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism

Sendai :

An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

Aguascalientes : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Chihuahua : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Mexico : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Mexico : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Amsterdam : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Gdansk : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Gdansk : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Krakow : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Lodz : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Warszawa : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

View More »

Warszawa : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Moscow : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Moscow : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Saint Petersburg : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Saint Petersburg : Research Site Updated

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism

Samara : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Banska Bystrica : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Bratislava : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Kosice : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Baracaldo : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Baracaldo : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Barcelona : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Barcelona : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Madrid : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

View More »

Santander : Hospital Universitario Marquès de Valdecilla

Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism

Valencia : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Antalya : Site Reference ID/Investigator# 68286

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Antalya : Site Reference ID/Investigator# 37822

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Antalya : Site Reference ID/Investigator# 40677

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Istanbul : Site Reference ID/Investigator# 40678

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Istanbul : Site Reference ID/Investigator# 40686

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

View More »

Istanbul : Site Reference ID/Investigator# 40672

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Istanbul : Site Reference ID/Investigator# 40674

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Istanbul : Site Reference ID/Investigator# 61585

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Istanbul : Site Reference ID/Investigator# 63765

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Istanbul : Site Reference ID/Investigator# 63766

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

İstanbul : Site Reference ID/Investigator# 69973

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Izmir : Site Reference ID/Investigator# 48127

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Karaman : Site Reference ID/Investigator# 64444

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Konya : Site Reference ID/Investigator# 48132

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Mersin : Site Reference ID/Investigator# 68281

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Mersin : Site Reference ID/Investigator# 69974

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Bristol : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

Glasgow : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

Leeds : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

Manchester : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

Nottingham : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease